Noninvasive markers of bone metabolism in the rhesus monkey: normal effects of age and gender.
Measurement of bone turnover in conditions such as osteoporosis has been limited by the need for invasive iliac bone biopsy to reliably determine parameters of bone metabolism. Recent advances in the area of serum and urinary markers of bone metabolism have raised the possibility for noninvasive measurements; however, little nonhuman primate data exist for these parameters. The purpose of this experiment was to define the normal range and variability of several of the newer noninvasive bone markers which are currently under investigation in humans. The primary intent was to determine age and gender variability, as well as provide some normative data for future experiments in nonhuman primates. Twenty-four rhesus macaques were divided into equal groups of male and female according to the following age groupings: 3 years, 5-10 years, 15-20 years, and > 25 years. Urine was collected three times daily for a four-day period and measured for several markers of bone turnoverm including pyridinoline (PYD), deoxypyrodinoline (DPD), hydroxyproline, and creatinine. Bone mineral density measurements of the lumbar spine were performed at the beginning and end of the study period. Serum was also obtained at the time of bone densitometry for measurement of osteocalcin levels by radioimmunoassay. There were no significant differences in bone mineral density, urine PYD, or urine DPD based on gender. Bone density was lowest in the youngest animals, peaked in the 15-20-year group, but again decreased in the oldest animals. The osteocalcin, PYD, and DPD levels followed an inversely related pattern to bone density. The most important result was the relative age insensitivity of the ratio of PYD:DPD in monkeys up to age 20 years. Since bone density changes take months or years to become measurable and iliac biopsies are invasive, the PYD/DPD marker ratio may have important implications for rapid noninvasive measurement of the effects of potential treatments for osteoporosis in the non-human primate model.
Cahoon
S
S
Department of Orthopaedic Surgery, Emory University School of Medicine, Yerkes Regional Primate Center, Atlanta, GA.
Boden
S D
SD
Gould
K G
KG
Vailas
A C
AC
D000367:Age Factors; D000818:Animals; D015415:Biomarkers / Q000652:urine; D015519:Bone Density / Q000502:physiology*; D004195:Disease Models, Animal; D005260:Female; D008253:Macaca mulatta / Q000378:metabolism*; D008297:Male; D015675:Osteocalcin / Q000097:blood; D010024:Osteoporosis / Q000503:physiopathology*; D011726:Pyridinium Compounds / Q000652:urine*; D012016:Reference Values; D012737:Sex Factors
D015415:Biomarkers; D011726:Pyridinium Compounds; D015675:Osteocalcin